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Recombination of homologous genes is a powerful mecha-
nism for generating sequence diversity, and can be applied
to protein analysis and directed evolution. In vitro recombi-
nation methods such as DNA shufﬂing are very ﬂexible and
can give hybrid genes with multiple crossovers; they have
been used extensively to evolve proteins with improved and
novel properties. In vivo recombination in both E. coli and
yeast isgreatly enhanced by double-strand breaks; for E.coli,
mutant strains are often necessary to obtain high efﬁciency.
Intra-and inter-molecularrecombination in vivo have distinct
features; both give hybrids with one or two crossovers, and
have been used to study structure-function relationships of
many proteins. Recently invivo recombination has been used
to generate diversity for directed evolution, creating a large
phage display antibody library. Recombination methods will
become increasingly useful in light of the explosion in ge-
nomic sequence data and potential for engineered proteins.
1. Introduction
Hybrids created by recombination of homologous
genes beneﬁt from the accumulated experience of evo-
lution. Although homologs have diverged in sequence
andofteninfunction,theirdifferencesmustbecompat-
ible with the same protein fold. Thus hybrid genes al-
lowalargejumpin“sequencespace”thatismuchmore
likely to give a correctly folded protein than a similar
jump due to randommutations. On a less radical scale,
once individual random mutations have been vetted by
selection, recombinationof these is more likely to give
functional proteins than new random mutations. Evo-
lution can proceedfaster with than without recombina-
tion (here meaning homologous recombination, unless
qualiﬁed).
These principles apply equally to genetic change in
nature or directed by man. Recombinationis pervasive
throughout nature and for sexual organisms is obliga-
tory at each generation. However, creation of hybrid
genes is less common than recombination between al-
leles; in the vast majorityof cases this is likely be dele-
terious [1], eventhoughfunctionalproteinsmay result.
Examples from human genetics include recombination
betweenδ and β globingenes to givehemoglobinLep-
ore [2], and recombination between red and green vi-
sual pigment genes resulting in color-blindness [3].
When rapid change is at a premium, as in the com-
petition between host and parasite, recombination can
be adapted to produce hybrid genes at very high rates.
Chickens (and also rabbits, pigs, and cows) generate
antibodydiversitybygeneconversion,arecombination
processthatcopiesbitsofsequencefrommultiplepseu-
dogenes into the single active antibody locus to create
many different antibody genes [4]. A strikingly simi-
lar process is used by the bacterium Borrelia burgdor-
feri during Lyme disease infection: mosaic versions of
the antigenic surface lipoprotein vlsE are generated by
geneconversionoftheactivevlsElocuswithanarrayof
silent vls cassettes [5,6]; switching between antigenic
variants allows evasion of the host immune response.
Recombination is also used for antigenic variation by
other pathogens including Borrelia helmsii, Neisseria,
and trypanosomes [7].
Just as nature ﬁnds recombination a useful tool, so
does the molecular biologist. This review is about
creating hybrid genes using in vitro recombinationand
in vivo recombinationin Escherichia coli and the yeast
Saccharomyces cerevisiae, those organisms in which
recombination is best understood. There are two main
reasons for creating hybrid genes. The ﬁrst is analysis:
hybridsareusefulforstudyingproteinfunctionbecause
theyaccessgeneticdifferencesyetarelikelytomaintain
three-dimensional structure. The second is directed
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evolution: recombination is an efﬁcient way to create
genetic variants that can be selected for improved or
novelfunctions. Differentrecombinationmethodshave
advantages and disadvantages for these two types of
applications.
2. In vitro recombination
Recombinationinvitrowasnotedearlyinthehistory
of PCR and was attributed to incompleteextensionand
re-annealing[8]. ThepercentageofPCR recombinants
couldbeincreasedbyshorteningtheextensiontimeper
cycle, and it was suggested that this might be useful
for producing populations of hybrid DNAs [9]. DNA
with breaks and other damage is particularly prone to
PCR-induced recombination [10]. Clearly, the ability
to undergo recombination is a direct consequence of
the complementary structure of DNA.
Stemmer demonstrated the usefulness of in vitro
recombination for directed evolution with his tech-
nique of “DNA shufﬂing” [11,12], also dubbed “sex-
ual PCR” [13]. A gene is cut into small fragments
with DNase I, and then re-assembled in a PCR-like
process that also tends to introduce point mutations
(Fig. 1(a)). The resulting products are subjected to se-
lection or screening, and the survivorsundergoanother
round of DNA shufﬂing. The ﬁrst round is no differ-
ent from error-prone PCR, but in subsequent rounds
the evolutionary speed-up expected from recombina-
tion comes into play. A further important advance was
to beginthe shufﬂingprocess with a set ofhomologous
genes (“family shufﬂing”) rather than a single gene,
tapping into sequence diversity derived from natural
evolution [14].
Related methods not involving DNA degradation
have been described. Random-priming in vitro recom-
bination (RPR) creates the short fragments needed for
re-assembly by primer extension of random oligonu-
cleotides (Fig. 1(b)) [15]. Staggered extension pro-
cess (StEP) comprises cycles of denaturationand poly-
merase extension where the amount of extension per
cycleisdeliberatelykeptshortbyshorttimesandlower
temperature [16,17]. The gradually extending chains
haveanopportunitytoswitchtemplateswitheachcycle
(Fig. 1(c)). Certain features are common to all these
in vitro methods. Mutations are likely due to the ex-
tensive use of in vitro polymerization. The usual pro-
tocols are intended to produce many crossovers; single
crossovers can be favored by altering parameters (such
as fragment size, cycling), but this will also increase
the percentage of non-recombinants. Similarly, as one
recombines increasingly divergent genes, re-assembly
of identical sequences will become strongly favored
and the percentage of non-recombinantswill increase.
Invitro recombinationhas beenappliedto theevolu-
tionofawiderangeofproteins[18,19]. Themajorityof
studies have shufﬂed only point mutations; the poten-
tial of family shufﬂing is just beginningto be explored.
Shufﬂing of four cephalosporinases gave greatly in-
creased activity against moxalactam [14]; shufﬂing
of two biphenyl dioxygenases gave novel substrate
ranges [20]; shufﬂing of two herpes thymidine kinases
gaveincreasedactivityonzidovudine(AZT)[21];shuf-
ﬂing of >20 human interferons gave better activity
towards mouse cells [22]; and shufﬂing of 26 differ-
ent subtilisin proteases gavecombinationsof improved
properties: thermostability, solvent tolerance, and ac-
tivity at acid or basic pH [23].
In vitro recombination has clearly been extremely
useful for directed evolution. It can generate hybrids
with many crossovers and it is very ﬂexible. It should
be very compatible with completely in vitro selection
technologies such as ribosome display [24], RNA dis-
play [25], and man-made compartments [26]. On the
other hand, for analysis of protein function the high
mosaicism and mutations generated by in vitro meth-
ods complicate interpretation of results and increase
the number of clones that need to be tested. They will
probably most useful when a selection or rapid screen
exists for the function of interest.
3. Mismatch repair
Aninterestingpartiallyinvivoapproachreliesnoton
recombination machinery but mismatch repair. DNAs
are constructed that are heteroduplex for the genes of
interest;aftertransformation,mismatchesarecorrected
in vivo (Fig. 2). If either there is no repair or if re-
pair is concerted, only parental genes will be recov-
ered. If onlysome mismatches are repairedor if not all
repairs use the same strand as template (“independent
repair”), then hybrid genes will result. The predomi-
nant mismatch repair pathway in E. coli does work by
a concerted mechanism: one strand is targeted for re-
placement synthesis, and these replacement tracts can
be several kilobases long [27]. Despite this, hybrid
genes have been observed after transformation of mul-
tiply mismatched heteroduplexes, usually at low fre-
quencies [28–31]. Heteroduplexes have typically been
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Fig. 1. In vitro recombination. Variations on PCR-like assembly of hybrid genes. Both DNA strands are pictured; existing DNA is a solid color,
newly synthesized DNA is striped. Oligonucleotide primers are depicted as open rectangles, and point mutations by small open ellipses. For all
methods, a smear is usually generated; a discrete-sized product is obtained by further cycling under conventional PCR conditions with speciﬁc
primers. a) DNA shufﬂing: fragmentation is usually done with DNase I, and the desired size range obtained by preparative gel electrophoresis.
Thermal cycling is similar to standard PCR. b) Random-primed recombination (RPR): random hexamer primers are extended with Klenow
polymerase; the size of the extension products is inversely related to the hexamer concentration used. Template and primers are removed by
ultraﬁltration. c) StEP: Speciﬁc primers are used, and polymerization is kept short by the cycle conditions: for example, 30 seconds at 94 ◦C then
5 seconds at 55◦C, repeated 80 times.
at different sites; heteroduplexes re-form circles hav-
ing nicks or single-strand gaps. Volkov et al. have
tested several heteroduplex methods for producing hy-
brid genes [32]. Their most effective method was
to anneal a gene heteroduplex from two asymmetric
PCRs and ligate this into a cut vector; 30% of transfor-
mantshadthedesiredcrossoverbetweentwomutations
463 bp apart.
4. In vivo recombination: Background
SomebackgroundaboutrecombinationinE.coliand
yeastis helpfulinunderstandingitsapplicationtomak-
ing hybrid genes. The primary reason recombination
evolved was probably not to generate sequence diver-
sity, buttorepairDNA damage. Recombinationis usu-
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Fig. 2. Mismatch repair. Different outcomes of a heteroduplex. A molecule is generated in vitro that has mismatches (pictured as spikes) only in
the genes of interest (thick lines), while the plasmid backbone (thin lines) is perfectly matched. Depending on how the molecule is assembled,
there may also be nicks or single-strand gaps, which are not shown. The pictured products are those occurring after any mismatch repair and one
round of replication.
especially double-strand breaks and crosslinks. The
initiationandoutcomeofrecombinationdependgreatly
on the precise structure of the DNA substrates – the
presence of gaps or breaks, the lengths (chromosome
vs plasmid), positioning of the homologous segments;
differentsubstrates may have different genetic require-
mentsforeffectiverecombination. Recentmodelshave
emphasized the inter-relationships between DNA re-
combination and replication ([33] and rest of that is-
sue.)
4.1. Recombination in E. coli
Genetic analysis has deﬁned three pathways of re-
combination in E. coli: the RecBCD, RecE, and RecF
pathways. Thepathwaydistinctionsareusefulbutsim-
plistic; in reality recombination is accomplished by
a network of genes, many shared between the “path-
ways”. ThemultifunctionalRecA proteinis critical for
most recombination reactions; it coats single-stranded
DNA and promotes its invasion into homologous du-
plex DNA and subsequent strand exchange. For re-
views on recombination in E. coli see [34,35].
TheRecBCDpathwayisthemajorpathwayforchro-
mosomal recombination in wildtype cells. However,
RecBCD is not normally involved in recombination
of small plasmids. RecBCD is a potent helicase and
nuclease that facilitates RecA loading onto the single
strands it creates. Interestingly, when only its nuclease
activityis inactivated(asinrecDstrains),intra-plasmid
recombination is increased [36,37]. The other two
recombination pathways were revealed by suppressor
mutationsthat restored chromosomalrecombinationto
recB recC strains. Both alternate pathways are much
more proﬁcient at intra-molecular plasmid recombina-
tion than wildtype, especially if a double-strand break
is present [38].
One suppressor genotype(recBC sbcB) activates the
RecF pathway for chromosomal recombination. Even
in wildtype cells, the RecF pathway mediates plasmid
recombination as this is inhibited by recF, recO, and
recR mutations. These genes also are important in
wildtype cells for recombinational repair of DNA le-
sions encountered during replication [35]. The other
suppressor genotype discovered was recBC sbcA, acti-
vating the RecE pathway. The sbcA mutation turns on
expression of recE and recT,a5 →3 exonuclease and
homologous pairing protein, respectively [39]. These
genes are functionally similar to the phage lambda re-
combinationgenesRedα and Redβ (also knownas exo
and bet), while the Redγ (or gam) gene inactivates
RecBCD – thus recombination in a recBC sbcA cell is
completelyanalogousto that in a cell infected by wild-
typephagelambda; in fact, recE andrecT are remnantsP.L. Wang / Creating hybrid genes by homologous recombination 7
of a lambda-like phage named Rac that integrated into
the E. coli genome long ago.
4.2. Recombination in yeast
Unlike in E. coli where mutant strains have advan-
tages for recombination, in yeast there is little need
for special genotypes. Wildtype yeast are highly pro-
ﬁcient at recombination, particularly at double-strand
breaks. Double-strand breaks are important for initi-
ating recombination during meiosis, and for switching
ofmating-typewhichoccursbygeneconversion. Over
10geneshavebeenimplicatedina recombinationepis-
tasis group that has RAD52 as its central member: all
typesofrecombinationappeartoinvolveRAD52,while
mutants in other members show only partial recombi-
nation defects. The group also includes RAD51, a ho-
mologofbacterialrecAthatalsocatalyzeshomologous
strand invasionand exchange. These and other RAD52
group genes have counterparts in mammalian cells, so
basicmechanismsarelikelytobeconservedfromyeast
to man. For a review on yeast recombination see [40].
5. In vivo recombination: Applications
An importantdistinction for recombinationmethods
is whether the substrates lie on the same or different
DNA molecules (intra- vs inter-molecular recombina-
tion). Intra-molecular recombination is more efﬁcient
since homology search is aided by the substrates be-
ing physically linked; however it usually involves a
specially constructed DNA. Inter-molecular recombi-
nationismuchmoreﬂexiblebutgenerallylessefﬁcient.
5.1. Intra-molecular plasmid recombination in E. coli
Weber and Weissman demonstrated the impor-
tance of double-strand breaks for efﬁcient recombina-
tion [41]. They ﬁrst created two plasmids with human
inteferon-α1 and α2 genes (∼80% nucleotide iden-
tity) having different resistance markers. Fragments
from each, sharing homology only within the inter-
feron genes, were ligated into linear concatamers and
transformed (Fig. 3(a)). Circularization occurred via
intra-molecular recombination in vivo, giving rise to
doubly-resistant colonies. DNA sequencing identiﬁed
11 different single-crossover products.
Subsequent workers have chosen to ﬁrst construct a
plasmid containing both homologs in head-to-tail ori-
entation, sometimes with intervening markers. Note
Fig. 3. In vivo recombination: Intra-molecular. a) The original
scheme of Weber and Weissman. Vectors with different antibiotic
resistance markers are digested. The fragments are puriﬁed and
ligated (the free ends have incompatible overhangs so a circle cannot
be generated); this is transformed and re-circularization occurs by
recombination. Inter-molecular recombination is also possible but
less likely. In most cases an intermediate plasmid is constructed
containing both genes of interest: b) recombination of circles is
infrequent, so a counter-selectable marker is required (“X”). c) If a
double-strand break is made between the genes, recombination can
re-create a circle; most surviving plasmids will be hybrids.
thatoneneedstoconstructtwoplasmids(withtheorder
of the genes reversed) to get hybrids of both polarities.
Thisplasmidisthensubjectedtoinvivorecombination,
eitheras a circleoras linearDNA.IfcircularDNAs are
used (Fig. 3(b)), it is important to have an intervening
counter-selectablemarkersuchasgalK[42]oraunique
restriction site [43] since the recombination frequency
is usually low. More commonly, the plasmid is cut
between the two homologs and transformed as a lin-
ear fragment (Fig. 3(c)) [44,45]; this provides double-
strand ends that stimulate recombination and also se-
lects for re-circularization since linear fragments can-
not replicate. Abastado et al. studied various factors
in this reaction [46]. Products were the result of single
crossovers, which were much more frequent near the
homologyends but distributed throughoutthe homolo-8 P.L. Wang / Creating hybrid genes by homologous recombination
gous region including more than 2.5 kb away from the
break. Heterologous sequence at one end had no dele-
terious effect, but heterology on both ends completely
blocked recombination. However, others observed re-
combination even with heterology on both ends [44,
45]. Surprisingly, recA is not required or is less im-
portant when a double-strandbreak is present [46–49].
One group found it advantageous to use a recBC sbcA
strain for creating hybrid genes by this approach [50].
Intra-molecular recombination in E. coli has been
used to create hybrids in a wide variety of gene fam-
ilies, for example: interferons [41], amylases [43],
lipases [51], adenylyl cyclases [52], insecticidal tox-
ins [49], recA [50], adenovirus E1A [53], outer mem-
brane proteins [44,45], major histocompatibility com-
plex antigens [46], neurotransmitter transporters [54],
cAMP receptors [55], and chemokine receptors [56].
The process has also been called “random chimerage-
nesis” [52]. The degree of identity ranged from 47–
90%; however,withsufﬁcientscreeningit waspossible
to identifya few in-framehybridsbetweencytochrome
P450 genes sharingonly 25% amino acid identity [57].
5.2. Intra- and inter-molecular plasmid
recombination in yeast
Pompon and Nicolas reported using both intra- and
inter-molecular recombination in yeast to create hy-
brid cytochrome P450 genes [58]. Intra-molecular re-
combination (Fig. 3(c)) was more efﬁcient than inter-
molecularrecombination(discussedbelow)[59]. Asin
E. coli, the majorityof transformantswere the result of
singlecrossovers,whichoccurredmostfrequentlynear
a double-strand end. Whereas rad52 mutation com-
pletelyeliminatesinter-molecularrecombination,ithas
muchlesseffectonintra-molecularrecombination[59].
However, intra-molecular recombination in yeast has
been little used for engineering purposes, presumably
since inter-molecularrecombinationis reasonably efﬁ-
cient and is much more ﬂexible.
Linear DNA fragments will readily undergo inter-
molecular recombination with another homologous
DNA in yeast [60]. Recombination of a fragment with
homologousends and a chromosomal locus (Fig. 4(a))
makes it simple to knock-outgenes in yeast. Recombi-
nationbetweenafragmentandacutplasmid(Fig.4(b))
is useful for plasmid construction [61,62]; recently it
was used to clone the entire complement of yeast cod-
ing sequences for two-hybrid and biochemical analy-
ses [63,64]. A similar reaction can be used to map
mutations in cloned genes [65,66]. Pompon and Nico-
Fig. 4. In vivo recombination: Inter-molecular. With two or more
recombining DNAs, there are many possibilities. Genes are pictured
as rectangles of various shades; identical vector sequences are thick
lines. a) Recombination of a linear fragment into an intact DNA is
an infrequent event, but can be selected for using a marker and can
be designed to inactivate the target locus. The target is shown as a
circular plasmid, but can also be a linear yeast chromosome. b) Plas-
mid construction by recombination (in vivo cloning). Agene ﬂanked
by sequences homologous to the vector (which may be appended by
PCR)isco-transformed withlinearized vector; recombination results
in a circle. c) Three-part hybrids: a gene fragment recombines with
a plasmid-borne homolog that is cut at an internal site. d) Two-part
hybrids: a gene fragment together with vector sequence recombines
with a homologous gapped plasmid. e) Multi-parent hybrids: mul-
tiple co-transformed mutant genes or homologs may ﬁrst recombine
with each other and then with the linearized vector.
las used it to make hybrid genes [58]. The gene on
one plasmid was cut at an internal restriction site and
co-transformed with a homologous gene on another
fragment, resulting in three-part hybrids (Fig. 4(c)).
Two-part hybrids can be made by using a fragment
with vector sequence at one end (Fig. 4(d)) [67]. Re-
combinationbetweendifferentcytochromeP450genes
(71% nucleotide identity) was 13–18-fold lower than
between identical genes. Recombination between the
yeast ARG4 gene and its human homolog (52% nu-
cleotide identity) produced very few and mostly aber-
rant plasmids, although two in-frame, functional re-
combinants were identiﬁed [68]. Crossovers are most
frequent near the double-strand breaks; treatment of
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distributionofcrossovers. Morecomplexhybrids(ﬁve-
part rather than three-part) can also occur [69]. Yeast
recombination was recently used to shufﬂe peroxidase
mutants for improved stability: when multiple donor
fragments were co-transformed, these could recom-
bine with each other in addition to the cut plasmid
(Fig. 4(e)) [70]. There have been fewer examples of
hybrid recombination in yeast than in E. coli; it has
mainly been used when gene expression will also be in
yeast.
5.3. Inter-molecular recombination in E. coli
Applications of inter-molecular recombination in E.
coli have so far mainly been for plasmid construction.
Recombination between two circular plasmids occurs
at low frequencies(∼104 in wildtypebacteria[71,72]),
but hybrid genes can be identiﬁed if one has a suitable
selection [73]. Analogous to the yeast reaction above
(Fig. 4(b)), insert and vector fragments whose ends
shared30bpidentitycouldrecombineinvivotocreatea
circularplasmid[74];eventhreeoverlappingfragments
can be recombined [75]. Several strains have been
used, including recA strains, but the reaction was more
efﬁcient in recBC sbcA [76] or recBC sbcB strains [77,
78]. A linear fragment with short end identities can
also recombineinto an intact DNA (Fig. 4(a)),but only
in recBC sbcAstrains andat a lowfrequency;the linear
fragment must confer an antibiotic resistance so that
recombinantscanbeselected[79]. Thisallowstargeted
mutagenesis of large DNAs such as bacterial artiﬁcial
chromosomes and the E. coli genome. Other strain
backgrounds can be used if the recombination genes
are provided on a plasmid [79,80]. Lambda Red genes
andrecDstrains havealsobeenusedforrecombination
of linear DNAs with the genome [81,82].
Inter-molecularrecombinationin E. coli can be used
for creating hybrid genes as in Fig. 4(c) and (d) [83].
WeobservedrecombinationonlyinrecBCsbcAstrains,
and not in wildtype, recD, or recBC sbcB strains. The
efﬁciency of recombination was high between identi-
cal sequences or ones with two small regions of mis-
match, but dropped signiﬁcantly for sequences shar-
ing 82% nucleotide identity (human and mouse p53
DNA binding domains). On the other hand, correct
hybrids were still obtained between sequences sharing
only56% identity(humanp53andp73). We generated
aseriesofhybridsbetweenmouseandchickenp53that
allowed us to map the epitopes of the two antibodies
that speciﬁcally recognize the wildtype conformation
of p53 and not cancer-derived p53 mutants. Because
theepitopesrequireaproperlyfoldedp53domain,they
cannot be analyzed using deletion mutants or peptide-
scanning. No special plasmid constructs are needed,
and both two-part and three-part hybrids can be di-
rectly created. In addition, recombination can easily
be iterated to make hybridsof hybridsfor more precise
analysis.
5.4. Phage delivery of genes for in vivo
recombination in E. coli
Thoughnumberofrecombinantsisnotusuallyalim-
iting factor when using recombinationfor analysis, the
need for DNA transformation imposes a practical limit
that is signiﬁcant for directed evolution experiments
– the more variants sampled, the better the chance of
ﬁnding a variant with the desired characteristics. Nu-
merical limitations can be partly overcome by using a
more efﬁcient way of getting DNA into cells, namely
by phage infection. Lambda phage have long been
used to study recombination, and can be used for cre-
ating hybrid genes [84,85]. Filamentous phage (Ff)
infection is particularly suitable because any plasmid
with an Ff origin (a “phagemid”) can be packaged as
infectious particles and because Ff phage display is a
powerful selection method. Grifﬁths et al. created a
very large antibody library by combining heavy- and
light-chain sub-libraries using Ff infection and site-
speciﬁc recombination [86]; recently a simpler format
has been developed [87]. Site-speciﬁc recombination
allows crossover at a ﬁxed point, whereas homologous
recombination allows crossover at many points and so
can generate a wider range of diversity.
Wehavecreatedalibrarybyhomologousrecombina-
tion in vivo (PLW and G. Winter; manuscript in prepa-
ration). In order to provide the conditions needed for
efﬁcient inter-molecularrecombination,we have made
arecBC sbcAstrainthatexpressestheEcoRIrestriction
system,allowingthecreationofdouble-strandbreaksin
vivo. We have also designed two phagemid vectors for
cloningantibodysingle-chainFv (scFv) genes (Fig. 5).
These are packaged as viral particles and co-infected
into the recombination strain. Upon entry they are cut
by EcoRI, releasing fragments that can recombine to
generate a phage display vector. One crossover oc-
curs within the antibody genes, the other within ampi-
cillin resistance (AmpR) gene fragments, resulting in
a hybrid antibody gene and a functional AmpR gene.
Sequences of progeny from an in vivo recombination
between two clones included a variety of hybrids, but10 P.L. Wang / Creating hybrid genes by homologous recombination
Fig. 5. In vivo double-strand break recombination: Hybrid anti-
bodies. Vectors for creating recombinant antibodies in vivo carry
elements for phage display (Ab-1, Ab-2, pIII) as well as overlap-
ping fragments of an ampicillin-resistance gene (5  -Amp, 3 -Amp).
DNAs are packaged as ﬁlamentous phage particles and efﬁciently
delivered into bacteria by infection. Double-strand breaks are gener-
ated in vivo byaction ofa restriction endonuclease, EcoRI,expressed
in the bacteria (irrelevant fragments that are also generated are not
shown.) Recombination of the homologous ends gives a hybrid an-
tibody (Ab-3) and a complete resistance gene (Amp), and re-creates
a plasmid circle.
crossovers were most common near the double-strand
ends.
Since chicken antibodies are natural products of ho-
mologous recombination, we made two small sub-
libraries of chicken scFv (<107 clones) and then re-
combined them in vivo by co-infection into 1 liter of
bacteria. This resulted in 8×1010 ampicillin-resistant
recombinants, which were directly used to produce
antibody-expressing phage. This library was selected
forantibodiestoseveralantigensincludinggroEL,p53,
Werner’s syndrome protein, ﬂuorescein, and Cy5. The
antibodies work well in ELISAs and in western blots.
Nucleotide polymorphisms allowed us to deﬁnitively
identify several of the antibody genes as hybrid prod-
ucts of recombination. This completely in vivo recom-
binationsystem should be generallyuseful for directed
evolution of antibodies and other genes for which se-
lection methods are available.
6. Conclusion
There are several ways to make hybrid genes, and
the best one will vary depending on the speciﬁc ap-
plication. All methods will perform less well as the
sequences to recombine become more divergent. Nat-
ural gene families often have alternating conserved
and variable regions, so despite low overall similar-
ity they may recombine readily in the conserved re-
gions. Intra-molecularrecombinationmay be more ef-
fective than inter-molecular recombination for gener-
ating hybrids between highly diverged homologs. But
certainly the lower reaches of similarity identiﬁable
bysequencecomparison(20–25%aminoacididentity)
or three-dimensional structure comparison will not be
amenable to homologousrecombinationmethods; per-
haps nonhomologousmethods may be useful for these
cases [88].
In vivo recombination can be done in either yeast or
E. coli. Recombination in yeast is highly efﬁcient, but
is most practical when the hybrid genes will also be
expressed in yeast. Recombination in mutant strains
of E. coli seems to be as powerful as recombination
in yeast and the hybrid genes created can either be
analyzed directly in E. coli for which many techniques
are available, or can be transfected into the species of
interest. Bothintra-andinter-molecularrecombination
can be used, with the latter being more ﬂexible.
For analysis of gene function, both in vitro and in
vivo recombination methods may be useful. In vivo
methods give simple hybrids and do not introduce mu-
tations; thismeansthatanorderedstrategycanbeused,
and fewer clones need to be tested and sequenced. If
a functional selection or rapid screen exists, then in
vitro recombination becomes more practical. And of-
ten analysis of function may shade into creating new
function, that is, directed evolution.
For directed evolution, in vitro recombination meth-
ods like DNA shufﬂing have the major advantage that
they can create hybrids with many crossovers. It is
importanttobe ableto bringtogetherseveralbeneﬁcial
mutationsthatmaybeanywhereinthesequence;ifone
is limited to one or two crossovers at a time this re-
quires more than one round of recombination. In vitroP.L. Wang / Creating hybrid genes by homologous recombination 11
recombination should be the method of choice for to-
tally in vitro selection methods. On the other hand, for
selections or screens requiring an in vivo step such as
phage display, two-hybrid, or gene complementation,
there may be practical advantages for in vivo recom-
bination methods; for example, we have used in vivo
recombinationto create a large antibody phage display
library.
Recombinational cloning and mutagenesis are prov-
ing to be important tools for genome-scale studies
of function (“functional genomics”). The explosion
of new homologs uncovered by genome sequencing
projects should also greatly beneﬁt recombinational
approaches to gene analysis and directed evolution.
They may even tell us something about natural evo-
lution by re-creating possible ancestors of current-day
molecules [89].
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